Mouse embryonic stem (ES) cells are used for generating knockout and knockin mouse models, which are crucial for biomedical research as well as pre-clinical studies.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pbx1a monoclonal antibodies to study transcriptional regulation, embryonic development, and tissue homeostasis.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pbx3a monoclonal antibodies to study transcriptional regulation and embryonic development.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pbx3b monoclonal antibodies to study transcriptional regulation and embryonic development.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pknox monoclonal antibodies to study transcriptional regulation, embryonic development, and tissue homeostasis.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Set1p monoclonal antibodies to study chromatin regulation and histone methylation.
Researchers in Dr. Michael Cleary's laboratory at Stanford University have developed a highly specific monoclonal antibody for AF5, a proto-oncoprotein associated with pediatric and adult acute leukemia.
Monoclonal antibody that recognizes MLL, an oncoprotein that is mutated in a broad subset of pediatric and adult leukemias. MLL protein displays histone methyltransferase activity.
Researchers in Dr. Michael Cleary's laboratory at Stanford University have developed a highly specific monoclonal antibody for AF4, a proto-oncoprotein associated with pediatric and adult leukemia.
Researchers in Dr. Michael Cleary's laboratory at Stanford University have developed a highly specific monoclonal antibody for ENL, a proto-oncoprotein associated with pediatric and adult leukemia.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pbx1b monoclonal antibodies to study transcriptional regulation, embryonic development, and tissue homeostasis.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pbx2 monoclonal antibodies to study transcriptional regulation, embryonic development, and tissue homeostasis.
Researchers in the laboratory of Dr. Michael Cleary at Stanford University have developed anti-Pbx (long form) monoclonal antibodies to study transcriptional regulation, embryonic development, and tissue homeostasis.
Researchers in the laboratory of Michael Cleary at Stanford University have developed a mouse that lacks the transcription factor Pbx1. Pbx1 is a proto-oncogene that was originally discovered at the site of chromosomal translocations in pediatric acute leukemia.